Literature DB >> 15903238

Production and glycosylation of recombinant beta-interferon in suspension and cytopore microcarrier cultures of CHO cells.

Maureen Spearman1, Jose Rodriguez, Norm Huzel, Michael Butler.   

Abstract

Microcarriers are suitable for high-density cultures of cells requiring surface attachment and also offer the advantage of easy media removal for product recovery. We have used the macroporous microcarriers Cytopore 1 and 2 for the growth of CHO cells producing recombinant human beta-interferon (beta-IFN) in stirred batch cultures. Although these cells may grow in suspension, in the presence of Cytopore microcarriers they become entrapped in the inner bead matrix where they can be maintained at high densities. Cell growth rates were reduced in microcarrier cultures compared to suspension cultures. However, the beta-IFN yield was up to 3-fold greater as a result of an almost 5-fold higher specific productivity. Maximum productivity was found in cultures containing 1.0 mg/mL of Cytopore 1 or 0.5 mg/mL of Cytopore 2 with a cell/bead ratio of 1029 and 822, respectively. Beta-IFN molecules aggregated in the later stages of all cultures, causing a decrease in response by ELISA. However, the degree of aggregation was significantly less in the microcarrier cultures. The N-linked glycans from beta-IFN were isolated and analyzed by normal phase HPLC. There was no apparent difference in the profile of glycans obtained from each of the suspension and Cytopore culture systems. This suggests that Cytopore microcarriers may be useful in bioprocess development for enhanced recombinant glycoprotein production without affecting the glycosylation profile of the protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15903238     DOI: 10.1021/bp0498084

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  7 in total

1.  Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells.

Authors:  François Lefloch; Bertrand Tessier; Sébastien Chenuet; Jean-Marc Guillaume; Pierre Cans; Jean-Louis Goergen; Annie Marc
Journal:  Cytotechnology       Date:  2006-12-29       Impact factor: 2.058

2.  Enhanced production of human recombinant proteins from CHO cells grown to high densities in macroporous microcarriers.

Authors:  T Tharmalingam; K Sunley; M Spearman; M Butler
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

3.  A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditions.

Authors:  Hengameh Aghamohseni; Maureen Spearman; Kaveh Ohadi; Katrin Braasch; Murray Moo-Young; Michael Butler; Hector M Budman
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-11       Impact factor: 3.346

4.  The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells.

Authors:  Jong Hyun Nam; Fuming Zhang; Myriam Ermonval; Robert J Linhardt; Susan T Sharfstein
Journal:  Biotechnol Bioeng       Date:  2008-08-15       Impact factor: 4.530

Review 5.  Towards Biomanufacturing of Cell-Derived Matrices.

Authors:  Weng Wan Chan; Fang Yu; Quang Bach Le; Sixun Chen; Marcus Yee; Deepak Choudhury
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

6.  The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody.

Authors:  Ana Rita Costa; Joanne Withers; Maria Elisa Rodrigues; Niaobh McLoughlin; Mariana Henriques; Rosário Oliveira; Pauline M Rudd; Joana Azeredo
Journal:  Springerplus       Date:  2013-01-28

Review 7.  Past, present, and future of microcarrier-based tissue engineering.

Authors:  Bingyan Li; Xin Wang; Yu Wang; Wenlong Gou; Xueling Yuan; Jiang Peng; Quanyi Guo; Shibi Lu
Journal:  J Orthop Translat       Date:  2015-03-13       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.